πŸ‡ΊπŸ‡Έ FDA
Patent

US 9278931

Cyclopropaneamine compound

granted A61KA61K31/167A61K31/36

Quick answer

US patent 9278931 (Cyclopropaneamine compound) held by Takeda Pharmaceutical Company Limited expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/167, A61K31/36, A61K31/366, A61K31/381